Clinical Trial Update: Safety and Immunogenicity of Haemophilus Influenzae Type b Conjugate Vaccine，Freeze-dried [Phase 3]

View source ↗

Summary

Phase 3 clinical trial update assessing the safety and immunogenicity of a freeze-dried Haemophilus influenzae type b conjugate vaccine; sponsor is Beijing Minh…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Haemophilus Influenzae Type Infection

Drugs mentioned

• Haemophilus influenzae type b conjugate vaccine, freeze-dried (Haemophilus influenzae type b conjugate vaccine)

Snippet

Sponsor: Beijing Minhai Biotechnology Co., Ltd | Conditions: Haemophilus Influenzae Type b Infections | Phase 3 | Status: UNKNOWN